---
title: "Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285611847.md"
description: "Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, \"Ginkgo\") issued a report on its financial performance for the initial quarter of 2026, concluded on March 31. The update comes subsequent to the sale of its Biosecurity division. On May 7, 2026, the company provided insights into its first-quarter results post the divestment. This announcement comes amidst a changing business landscape for Ginkgo as it navigates new strategic directions."
datetime: "2026-05-07T20:08:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285611847.md)
  - [en](https://longbridge.com/en/news/285611847.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285611847.md)
---

# Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") issued a report on its financial performance for the initial quarter of 2026, concluded on March 31. The update comes subsequent to the sale of its Biosecurity division. On May 7, 2026, the company provided insights into its first-quarter results post the divestment. This announcement comes amidst a changing business landscape for Ginkgo as it navigates new strategic directions.

### Related Stocks

- [DNA.US](https://longbridge.com/en/quote/DNA.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [DNABW.US](https://longbridge.com/en/quote/DNABW.US.md)

## Related News & Research

- [09:00 ETThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA](https://longbridge.com/en/news/287639188.md)
- [Aligos Therapeutics Presents Positive Data at the EASL Congress 2026 | ALGS Stock News](https://longbridge.com/en/news/287726278.md)
- [Chief Medical Officer Sells MBX for $2.7 Million After Monster 2026 Run](https://longbridge.com/en/news/287812753.md)
- [Pharming Group announces results of 2026 Annual General Meeting of Shareholders | PHARM Stock News](https://longbridge.com/en/news/287938285.md)
- [COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE | CLGN Stock News](https://longbridge.com/en/news/288057200.md)